Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Harvey’s British Eatery is a 35 to 40 cover eatery focused on re-establishing the heritage of British cooking. Harvey’s recipes draw on the best in the British Isles, using seasonal ingredients. The investment will be used to take their eatery to a permanent site in London.
(SEIS partial)
days to go:
Expired
investment:
£193,550
10Cast forensic forecasting is a cloud and mobile AI application that integrates with legacy CRM systems to improve B2B forecasting.
days to go:
Expired
investment:
£90,056
Launched in October 2016, Big Drop Brewing is a world-leading alcohol-free craft brewer. The company brews beer naturally by using specialist brewing methods to ensure the alcohol never exceeds 0.5%. The beer is not only Alcohol-Free, but is also gluten-free and many are low in sugar. Their award-winning lager is vegan-friendly. The company does not have a brewery of its own but partners with reputable breweries around the world, who share their brewing values to produce the beer. Big Drop Brewing has secured private funding already and meaningful distribution in the UK and 12 overseas markets. They have also secured off-trade listings in Tesco, Morrisons and Ocado. Half of the investment will be used for Sales & Marketing, 30% for new branding launch and related marketing, 10% for production costs and the remaining 10% for product development.
days to go:
Expired
investment:
£617,566
East London Liquor Company export from east London to 20 countries worldwide. They have plans to launch in Ibiza, Toronto, Los angles, New York and Shanghai. They also own their own restaurant. Since 2014 they have grown there team from 4 to 30 people. London dry gin has won many award and the East London Liquor Company produces over 12,000 bottles of gin a month.
days to go:
Expired
investment:
£1,326,450
Software as a Service (SaaS) business for Recruitment generating recurring revenues on a scalable cloud platform. Used by HR, Recruiting Teams and HR Managers. Proven that we can sell to our target market we seek growth capital to build out our chosen go to market strategy.
days to go:
Expired
investment:
£280,000
